Bio Green Med Solution free cash flow BGMS
Cash from operations less capital spending, by quarter and over the last twelve months, from 2012.
- Last 12 months, to Jun 30, 2026
- n/m
- a quarter missing
- Latest quarter, Q2 FY26
- −$352K
- Fiscal year 2023
- −$16.1M
Bio Green Med Solution's twelve-month free cash flow can't be added up yet: a quarter of its results is missing from our data.
In its latest quarter, Q2 FY26, it was −$352K.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2023 | −$16.1M | n/a |
| FY2022 | −$20.8M | n/a |
| FY2021 | −$18.6M | n/a |
| FY2020 | −$8M | n/a |
| FY2019 | −$9.5M | n/a |
| FY2018 | −$6.7M | n/a |
| FY2017 | −$7.5M | n/a |
| FY2015 | −$14.5M | n/a |
| FY2014 | −$19M | n/a |
| FY2013 | n/a | n/a |
| FY2012 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$352K | n/a | n/a | |
| Q1 FY26 | −$279K | n/a | n/a | |
| Q3 FY24 | −$3.1M | n/a | n/a | |
| Q4 FY23 | −$3.9M | n/a | −$16.1M | |
| Q3 FY23 | −$4M | n/a | −$17.4M | |
| Q2 FY23 | −$1.3M | n/a | −$20.3M | |
| Q1 FY23 | −$6.9M | n/a | −$20.9M | |
| Q4 FY22 | −$5.2M | n/a | −$20.8M | |
| Q3 FY22 | −$7M | n/a | −$20.2M | |
| Q2 FY22 | −$1.9M | n/a | −$19.5M | |
| Q1 FY22 | −$6.8M | n/a | −$21.7M | |
| Q4 FY21 | −$4.6M | n/a | −$18.6M |
Against its peers
Companies in Industrials nearest Bio Green Med Solution's size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| BGMSBio Green Med Solution | n/m |
| AERTAeries Technology | 28.4% |
| MAMOMassimo | n/m |
| ACFNAcorn Energy | n/m |
| Peer median | 28.4% |
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Bio Green Med Solution
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.